ZNF224 and chronic myelogenous leukemia, BCR-ABL1 positive: As shown in Figure 1, the expression levels of ZNF224 were significantly lower in BCR-ABL positive cell lines as well as in CD34+ primary cells from CML patients with respect to BCR-ABL negative cell lines.